HealthcareOn the MoveBiogen Idec (BIIB +4%) moves higher after BofA/ Merrill Lynch upgrades the shares to Buy from...Apr. 12, 2013 10:33 AM ETBiogen Inc. (BIIB) StockBIIBBy: Colin Lokey, SA News EditorBiogen Idec (BIIB +4%) moves higher after BofA/ Merrill Lynch upgrades the shares to Buy from Neutral. Price target raised to $246 from $187.Recommended For YouMore Trending NewsSee More »About BIIB StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgBIIB--Biogen Inc.Trending AnalysisTrending News